These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 9689672

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prostaglandin E1 and the nitric oxide donor linsidomine for erectile failure: a diagnostic comparative study of 40 patients.
    Porst H.
    J Urol; 1993 May; 149(5 Pt 2):1280-3. PubMed ID: 8479015
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term efficacy and safety of self-intracavernous injection of prostaglandin E1 for treatment of erectile dysfunction in China.
    He L, Wen J, Jiang X, Chen H, Tang Y.
    Andrologia; 2011 Jun; 43(3):208-12. PubMed ID: 21486416
    [Abstract] [Full Text] [Related]

  • 12. [Prostaglandin E1 in the diagnosis and therapy of erectile disorders].
    Loran OB, Segal AS, Shcheplev PA.
    Urol Nefrol (Mosk); 1995 Jun; (4):35-8. PubMed ID: 7571200
    [Abstract] [Full Text] [Related]

  • 13. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W, de la Fuente RB, Lycklama à Nijeholt AA, Vermeij P, Zwartendijk J.
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nocturnal penile tumescence activity unchanged after long-term intracavernous injection therapy.
    Maniam P, Seftel AD, Corty EW, Rutchik SD, Hampel N, Althof SE.
    J Urol; 2001 Mar; 165(3):830-2; discussion 832-3. PubMed ID: 11176480
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.
    Raina R, Lakin MM, Agarwal A, Ausmundson S, Montague DK, Zippe CD.
    Urology; 2004 Mar; 63(3):532-7; discussion 538. PubMed ID: 15028452
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Some aspects of the use of prostaglandin E1 in cases of erectile dysfunction].
    Fekete F.
    Orv Hetil; 1997 Jun 22; 138(25):1631-4. PubMed ID: 9265144
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of sexual impotency by intra-cavernous injections of prostaglandin E1. Report of 180 patients].
    Amar E, Kobelinsky M, Khoury R, Sarkis P, Bouyer I, Dauphin A, Delmas V, Boccon-Gibod L.
    Prog Urol; 1993 Dec 22; 3(6):971-8. PubMed ID: 8305940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.